Moderna Inc

Cambridge-headquartered American biotech company Moderna Inc (NASDAQ:MRNA) is engaged in developing mRNA-based medicines for a broad range of disorders including rare diseases, infectious diseases, cardiovascular disease, and cancers. The Company has manufactured an mRNA vaccine that utilizes genetic material part of SARS-CoV-2 virus to stimulate an immune response from the human body.

Similar Companies